3.03
-0.66%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Guizhou Xinbang Pharmaceutical Co
Its shares trade on Shenzhen under the ticker 002390.SZ. It has been listed since 16 April 2010. In the fiscal year to 31 December 2024, it reported revenue of CN¥6.03bn and net income of CN¥101.4m. At that date it held total assets of CN¥9.03bn and shareholders' equity of CN¥6.71bn.
Guizhou Xinbang Pharmaceutical Co., Ltd. engages in the manufacture and sale of Chinese herbal medicine and bio pharmaceutical products. The company is headquartered in Guiyang, Guizhou. The company went IPO on 2010-04-16. The firm operates its businesses through three segments. The Pharmaceutical Manufacturing segment is engaged in the manufacture and distribution of Chinese patent medicines, such as Ginkgo Leaves Tablets. The Pharmaceutical Distribution segment includes rapid wholesale business and medicine retail business. The Medical Services segment is engaged in the provision of medical services. The company operates its businesses primarily in domestic markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 16 Apr 2010
- Employees
- 5,408
- Website
- xinbang.com ↗
Leadership
Pay as last reported
- Ms. Ji AnChairman of the Board, since 2022CN¥791,700
- Ms. Yayun XiaoChief Financial Officer, Deputy General ManagerCN¥491,700
- Ms. Lingzhong KongGeneral Manager, Director, since 2003CN¥791,700
- Ms. Chuan ChenDeputy General Manager, Secretary of the BoardCN¥491,700
- Ms. Yafang LuDeputy General ManagerCN¥491,700
- Mr. Chi LuoDeputy General ManagerCN¥491,600
- Mr. Jieqing ZhangDeputy General Manager, since 2020CN¥551,600
- Ms. Yi DingDirector
- Ms. Xiangqian LuDirector
- Ms. Qianxian MaDirector
- Mr. Jie LiuIndependent DirectorCN¥40,000
- Mr. Yifeng LiuIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 41
- Environment
- 41
- Social
- 14
- Governance
- 70
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Guizhou Xinbang Pharmaceutical employs 5,408 full-time employees in Guiyang, CN.
- The company's Pharmaceutical Manufacturing segment produces Ginkgo Leaves Tablets.
- Guizhou Xinbang operates three business segments within the Health Care sector.
Weaknesses
- Guizhou Xinbang's business is primarily domestic, limiting international expansion.
- The company's reliance on Chinese herbal medicine may face regulatory challenges.
- The firm's IPO in 2010 may indicate limited recent capital investment.
Opportunities
- Expanding the Medical Services segment could increase market share in China.
- Growing demand for bio pharmaceutical products presents new market opportunities.
- The Pharmaceutical Distribution segment can leverage rapid wholesale business growth.
Threats
- Regulatory changes in the Chinese Health Care sector could impact operations.
- Competition from domestic pharmaceutical companies may intensify.
- Economic downturns in China could reduce consumer spending on medicines.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.